BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36309205)

  • 1. YAP/TAZ-TEAD is a novel transcriptional regulator of genes encoding steroidogenic enzymes in rat granulosa cells and KGN cells.
    Mizutani T; Orisaka M; Kawabe S; Morichika R; Uesaka M; Yoshida Y
    Mol Cell Endocrinol; 2023 Jan; 559():111808. PubMed ID: 36309205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of YAP/TAZ-TEAD activity induces cytotrophoblast differentiation into syncytiotrophoblast in human trophoblast.
    Mizutani T; Orisaka M; Miyazaki Y; Morichika R; Uesaka M; Miyamoto K; Yoshida Y
    Mol Hum Reprod; 2022 Sep; 28(10):. PubMed ID: 35993908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FSH Regulates YAP-TEAD Transcriptional Activity in Bovine Granulosa Cells to Allow the Future Dominant Follicle to Exert Its Augmented Estrogenic Capacity.
    de Andrade LG; Portela VM; Dos Santos EC; Aires KV; Ferreira R; Missio D; da Silva Z; Koch J; Antoniazzi AQ; Gonçalves PBD; Zamberlam G
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Hippo pathway signaling and A-kinase anchoring protein 13 in primordial follicle activation and inhibition.
    Maher JY; Islam MS; Yin O; Brennan J; Gough E; Driggers P; Segars J
    F S Sci; 2022 May; 3(2):118-129. PubMed ID: 35560009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Hippo pathway mediates inhibition of vascular smooth muscle cell proliferation by cAMP.
    Kimura TE; Duggirala A; Smith MC; White S; Sala-Newby GB; Newby AC; Bond M
    J Mol Cell Cardiol; 2016 Jan; 90():1-10. PubMed ID: 26625714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YAP regulates cell proliferation, migration, and steroidogenesis in adult granulosa cell tumors.
    Fu D; Lv X; Hua G; He C; Dong J; Lele SM; Li DW; Zhai Q; Davis JS; Wang C
    Endocr Relat Cancer; 2014 Apr; 21(2):297-310. PubMed ID: 24389730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the YAP/TAZ-TEAD Transcriptional Complex in the Metabolic Control of TRAIL Sensitivity by the Mevalonate Pathway in Cancer Cells.
    El Yousfi Y; Mora-Molina R; López-Rivas A; Yerbes R
    Cells; 2023 Sep; 12(19):. PubMed ID: 37830584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation.
    He L; Pratt H; Gao M; Wei F; Weng Z; Struhl K
    Elife; 2021 Aug; 10():. PubMed ID: 34463254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanosignaling YAP/TAZ-TEAD Axis Regulates the Immunomodulatory Properties of Mesenchymal Stem Cells.
    Yoshii H; Kajiya M; Yoshino M; Morimoto S; Horikoshi S; Tari M; Motoike S; Iwata T; Ouhara K; Ando T; Yoshimoto T; Shintani T; Mizuno N
    Stem Cell Rev Rep; 2024 Jan; 20(1):347-361. PubMed ID: 37917410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric Modulation of the YAP/TAZ-TEAD Interaction by Palmitoylation and Small-Molecule Inhibitors.
    Mills KR; Misra J; Torabifard H
    J Phys Chem B; 2024 Apr; 128(16):3795-3806. PubMed ID: 38606592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Irreversible TEAD Inhibitor, SWTX-143, Blocks Hippo Pathway Transcriptional Output and Causes Tumor Regression in Preclinical Mesothelioma Models.
    Hillen H; Candi A; Vanderhoydonck B; Kowalczyk W; Sansores-Garcia L; Kesikiadou EC; Van Huffel L; Spiessens L; Nijs M; Soons E; Haeck W; Klaassen H; Smets W; Spieser SA; Marchand A; Chaltin P; Ciesielski F; Debaene F; Chen L; Kamal A; Gwaltney SL; Versele M; Halder GA
    Mol Cancer Ther; 2024 Jan; 23(1):3-13. PubMed ID: 37748190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a cryptic site at the interface 2 of TEAD - Towards a new family of YAP/TAZ-TEAD inhibitors.
    Sturbaut M; Bailly F; Coevoet M; Sileo P; Pugniere M; Liberelle M; Magnez R; Thuru X; Chartier-Harlin MC; Melnyk P; Gelin M; Allemand F; Guichou JF; Cotelle P
    Eur J Med Chem; 2021 Dec; 226():113835. PubMed ID: 34509860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review.
    Crawford JJ; Bronner SM; Zbieg JR
    Expert Opin Ther Pat; 2018 Dec; 28(12):867-873. PubMed ID: 30482112
    [No Abstract]   [Full Text] [Related]  

  • 14. Convergence of YAP/TAZ, TEAD and TP63 activity is associated with bronchial premalignant severity and progression.
    Ning B; Tilston-Lunel AM; Simonetti J; Hicks-Berthet J; Matschulat A; Pfefferkorn R; Spira A; Edwards M; Mazzilli S; Lenburg ME; Beane JE; Varelas X
    J Exp Clin Cancer Res; 2023 May; 42(1):116. PubMed ID: 37150829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CREB coactivator CRTC2/TORC2 and its regulator calcineurin crucially mediate follicle-stimulating hormone and transforming growth factor β1 upregulation of steroidogenesis.
    Fang WL; Lee MT; Wu LS; Chen YJ; Mason J; Ke FC; Hwang JJ
    J Cell Physiol; 2012 Jun; 227(6):2430-40. PubMed ID: 21826657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanosensitive transcriptional coactivators MRTF-A and YAP/TAZ regulate nucleus pulposus cell phenotype through cell shape.
    Fearing BV; Jing L; Barcellona MN; Witte SE; Buchowski JM; Zebala LP; Kelly MP; Luhmann S; Gupta MC; Pathak A; Setton LA
    FASEB J; 2019 Dec; 33(12):14022-14035. PubMed ID: 31638828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutual regulation of growth hormone and bone morphogenetic protein system in steroidogenesis by rat granulosa cells.
    Nakamura E; Otsuka F; Inagaki K; Miyoshi T; Matsumoto Y; Ogura K; Tsukamoto N; Takeda M; Makino H
    Endocrinology; 2012 Jan; 153(1):469-80. PubMed ID: 22067323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the acylation of TEAD4 on its interaction with co-activators YAP and TAZ.
    Mesrouze Y; Meyerhofer M; Bokhovchuk F; Fontana P; Zimmermann C; Martin T; Delaunay C; Izaac A; Kallen J; Schmelzle T; Erdmann D; Chène P
    Protein Sci; 2017 Dec; 26(12):2399-2409. PubMed ID: 28960584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress with YAP/TAZ-TEAD inhibitors: a patent review (2018-present).
    Zagiel B; Melnyk P; Cotelle P
    Expert Opin Ther Pat; 2022 Aug; 32(8):899-912. PubMed ID: 35768160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Hippo pathway effectors YAP and TAZ interact with EGF-like signaling to regulate expansion-related events in bovine cumulus cells in vitro.
    Koch J; Portela VM; Dos Santos EC; Missio D; de Andrade LG; da Silva Z; Gasperin BG; Antoniazzi AQ; Gonçalves PBD; Zamberlam G
    J Assist Reprod Genet; 2022 Feb; 39(2):481-492. PubMed ID: 35091965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.